Expert Consensus on practical issues of using topical activated zinc pyrithione in dermatology

On April 10, 2025, the Expert Consensus on the topic “Practical issues of using activated zinc pyrithione in dermatology” was held in Moscow. The issues of the role of external non-hormonal anti-inflammatory therapy in the management of patients with chronic dermatoses and the possibilities and feasibility of using activated zinc pyrithione in dermatology were discussed. The key aspects of the use of the topical drug Skin Cap in patients with seborrheic dermatitis, psoriasis, atopic dermatitis, steroid rosacea were identified and the main practical advantages of using the topical drug Skin Cap in the treatment algorithms for patients with chronic dermatoses were highlighted.

1. Zhukov A. S., Lavrov N. V., Khairutdinov V.R., Samtsov A. V. Models of psoriasis in laboratory animals: the current state of the problem. Immunology. 2019; 40 (2): 64–69. (In Russ.).

2. Zhukov A. S., Khairutdinov V.R., Samtsov A. V. Comparative study of the anti-inflammatory activity of zinc pyrithione in a laboratory model of psoriasis. 2020; 97 (2): 64–70. (In Russ.).

3. Clinical guidelines «Atopic dermatitis in children». Union of Pediatricians of Russia, Russian Association of Allergists and Clinical Immunologists. Russian Society of Dermatovenerologists and Cosmetologists. Moscow, 2024. 60 p. (In Russ.).

4. Clinical guidelines «Psoriasis». All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists». Moscow, 2023. (In Russ.).

5. Clinical guidelines «Seborrheic dermatitis». All-Russian public organization «Russian Society of Dermatovenerologists and Cosmetologists». Moscow, 2022. (In Russ.).

6. Kruglova LS, Gryazeva NV, Uspenskaya PA Topical therapy of psoriasis: algorithms for the use of activated zinc pyrithione. Medical alphabet. 2024; (25): 59–64. (In Russ.).

7. Kruglova LS, Perminova MA, Shabliy RA Activated zinc pyrithione – the possibility of long-term control over psoriasis. Clinical dermatology and venereology. 2012; (1): 67–72. (In Russ.).

8. Kruglova L. S., Petriy M. N., Gensler E. M. Evaluation of the effectiveness of activated zinc pyrithione in the treatment of patients with psoriasis. Clinical dermatology and venereology. 2019; 18 (5): 616–623. (In Russ.).

9. Kruglova LS, Rubtsova LA Perioral dermatitis: modern methods of therapy. Medical Alphabet «Dermatology» (2) MA No. 27 (521). 2022. P. 40–45. (In Russ.).

10. Kubanov AA, Petrovsky FI. Effect of effective therapy (activated zinc pyrithione (Skin-cap) on the quality of life of patients with psoriasis. Bulletin of dermatology and venereology. 2008; 2: 80–85. (In Russ.).

11. Kubanova AA Activated zinc pyrithione (Skin-cap) in the treatment of mild and moderate forms of papular plaque psoriasis, results of a randomized, placebo-controlled study «Anthracite». Bulletin of dermatology and venereology. 2008; 1: 59–65. (In Russ.).

12. Latiy O.V., Belousova I. E., Samtsov A.V. Immunohistological features of the use of Skin-cap in comparison with external steroids in patients with atopic dermatitis. Bulletin of dermatology and venereology. 2005. No. 1. P. 46–50. (In Russ.).

13. Том 20. № 1. С. 28–34. Markelova E.M., Kruglova L. S., Gryazeva N. V. Experience in the use of various forms of zinc pyrithione in seborrheic dermatitis. Effective pharmacotherapy. 2023. Vol. 20. No. 1. P. 28–34. (In Russ.).

14. Mokronosova M.A., Maksimova A. E., Baturo A.P., Kataeva O. V. Effect of various methods of external therapy on the colonization of the skin with S. aureus and the course of atopic dermatitis, Russian Journal of Allergology 2004; No. 1: 58–61. (In Russ.).

15. Perlamutrov Yu.N., Olkhovskaya K. B. Treatment of withdrawal dermatitis after the use of topical glucocorticosteroids using activated zinc pyrithione. Bulletin of Dermatology and Venereology, 2011; (6): 24–31. (In Russ.).

16. Registration number of the accreditation certificate No. ROSS RU. 001.21 AYu22 (State Standard of Russia). (In Russ.).

17. Samtsov A. V. Acne and acneiform dermatoses. Monograph. 2nd edition supplemented and revised. Moscow: 2014. 352 p. (In Russ.).

18. Fassakhov RS Zinc pyrithione in the complex therapy of atopic dermatitis: pathogenetic rationale and research results. Medical Council. 2017; 20: 171–176. (In Russ.).

19. Fassakhov R. S., Pampura A.N., Korostovtsev D. S. et al. Zinc pyrithione (Skin-cap) in the therapy of atopic dermatitis in children (based on the results of the Russian multicenter study CADET). Russian Allergological Journal, 2007, 2: 75–81. (In Russ.).

20. Rowlands C. G., Danby F. W. Histopathology of psoriasis treated with zinc pyrithione. Am. J. Dermatopathol. 2000; 22 (3): 272–276.